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Summary
HIV-1 transcriptional activator (Tat) enables viral transcription and is also actively released by infected cells. Extracellular Tat can enter
uninfected cells and affect some cellular functions. Here, we examine the effects of Tat protein on the secretory activity of
neuroendocrine cells. When added to the culture medium of chromaffin and PC12 cells, Tat was actively internalized and strongly
impaired exocytosis as measured by carbon fiber amperometry and growth hormone release assay. Expression of Tat mutants that do not
bind to phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P2] did not affect secretion, and overexpression of phosphatidylinositol 4-
phosphate 5-kinase (PIP5K), the major PtdIns(4,5)P2 synthesizing enzyme, significantly rescued the Tat-induced inhibition of
neurosecretion. This suggests that the inhibition of exocytosis may be the consequence of PtdIns(4,5)P2 sequestration. Accordingly,
expression of Tat in PC12 cells interfered with the secretagogue-dependent recruitment of annexin A2 to the plasma membrane, a
PtdIns(4,5)P2-binding protein that promotes the formation of lipid microdomains that are required for exocytosis. In addition Tat
significantly prevented the reorganization of the actin cytoskeleton necessary for the movement of secretory vesicles towards plasma
membrane fusion sites. Thus, the capacity of extracellular Tat to enter neuroendocrine cells and sequester plasma membrane
PtdIns(4,5)P2 perturbs several PtdIns(4,5)P2-dependent players of the exocytotic machinery, thereby affecting neurosecretion. We
propose that Tat-induced inhibition of exocytosis is involved in the neuronal disorders associated with HIV-1 infection.
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Introduction
The human immunodeficiency virus type I (HIV-1) transcriptional
activator (Tat) is essential for viral gene expression and replication
(Berkhout and Jeang, 1989; Gaynor, 1995). Tat is an ,11 kDa
basic protein that is actively released by infected T-cells into the
extracellular medium (Ensoli et al., 1990; Rayne et al., 2010a). Tat
does not have a signal sequence and is unconventionally secreted
(Rayne et al., 2010b). Circulating Tat in the serum of HIV patients
can reach nanomolar concentrations (Westendorp et al., 1995;
Xiao et al., 2000). Tat is also present within the central nervous
system (CNS) since it can cross the blood brain barrier and be
produced in situ by HIV-1-infected cells such as macrophages and
microglia. Thus, Tat may be involved in HIV-1 neuropathogenesis
(Banks et al., 2005). HIV-1-associated neuronal symptoms include
motor or cognitive dysfunctions and behavioral changes affecting
nearly 30% of patients undergoing intensive chemotherapy.
Moreover, 10% of patients develop HIV-1-associated dementia
at the late stage of AIDS (Ghafouri et al., 2006). The molecular
details underlying these CNS perturbations during HIV-1 infection
are scarce.
It is generally believed that extracellular Tat operates as a viral
toxin (Huigen et al., 2004; Rubartelli et al., 1998) that can enter
several types of uninfected cells and affect their physiology (Li
et al., 2009). Tat internalization seems to involve different
pathways depending on cell type. Indeed, Tat can enter HeLa
cells using caveolar endocytosis (Tyagi et al., 2001), and T-cells
using clathrin/AP-2-dependent uptake (Vendeville et al., 2004).
In neurons, extracellular Tat interacts with the low-density
lipoprotein receptor-related protein (LRP) and is then
internalized into endosomal structures (Liu et al., 2000), where
Tat concentration can reach 2 pg/ml (Deshmane et al., 2011).
Upon delivery to endosomes, the amino acid tryptophan 11
initiates Tat insertion into the late endosome membrane (Yezid
et al., 2009). Tat transmembrane transport is then catalyzed by
the cytosolic chaperone Hsp90 that helps Tat to refold on the
trans side of the endosomal membrane (Vendeville et al., 2004).
Phosphoinositides control the activity of many membrane
protein complexes implicated in a variety of signaling and
trafficking pathways including neurosecretion (Balla and Varna´i,
2009). PtdIns(4,5)P2 is a key phospholipid concentrated on the
cytoplasmic leaflet of the plasma membrane where it functions as
a recruiting platform for proteins that are essential components of
the exocytotic or endocytotic machineries (Di Paolo and De
Camilli, 2006; van den Bout and Divecha, 2009). The PHPLCd–
GFP fusion protein has been widely used to visualize
PtdIns(4,5)P2 at exocytotic sites in neuroendocrine cells and
PHPLCd–GFP overexpression inhibits exocytosis in chromaffin
cells (Holz et al., 2000). Since Tat was recently shown to bind to
PtdIns(4,5)P2 with a high affinity (Rayne et al., 2010b), we
examined whether Tat might affect neurosecretion by altering
PtdIns(4,5)P2-dependent processes. We show here that
extracellular Tat is able to enter chromaffin and PC12 cells.
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Once internalized, Tat strongly inhibits hormone secretion. We
observed that Tat modifies the localization of annexin A2, a
major organizer of the exocytotic platform in neuroendocrine
cells (Umbrecht-Jenck et al., 2010). Tat also affects the
reorganization of the cortical actin cytoskeleton required for
exocytosis in neuroendocrine cells. Thus, through its capacity to
bind PtdIns(4,5)P2, Tat profoundly disorganizes the exocytotic
machinery leading to the inhibition of neurosecretion.
Results
Exogenous Tat is internalized by endocytosis in
neurosecretory cells
We first examined whether extracellular Tat could enter
neuroendocrine cells. After a 30 min incubation on ice with
recombinant Tat, PC12 cells were chased at 37 C˚ for different
periods of time. At time zero, Tat was mostly observed at the cell
periphery, showing continuous staining along the cell membrane
(Fig. 1A). This Tat labeling at the cell periphery was also detected
in the absence of cell permeabilization (data not shown),
suggesting that at this early time point, Tat is mostly associated
with the extracellular face of the plasma membrane. After a 20 min
chase at 37 C˚, Tat was not detected anymore at the cell periphery
but on early endosomal structures labeled with EEA1 (Fig. 1A).
Quantification revealed colocalization of Tat with EEA1, being
maximal (5061.8%) after a 20 min chase and thereafter
decreasing (Fig. 1B). At later chase times, Tat was observed in
vesicles labeled with the late endo-lysosomal marker Lamp-1: Tat/
Lamp-1 colocalization peaked at 2 hours and then decreased to be
barely significant after 4–6 hours (supplementary material Fig.
S1). Interestingly, after 4–6 hours of chase Tat could be detected
again at the plasma membrane (Fig. 1A, arrowheads).
To confirm that Tat transits to the plasma membrane, we
performed double staining experiments with syntaxin 1A, a
specific plasma membrane marker in neurosecretory cells
(Fig. 1C,D). At 20 min, there was almost no colocalization
between Tat and syntaxin 1A (961.4%). However, after 4 hours
of chase, the presence of Tat at the plasma membrane was
revealed by a significant increase in Tat/syntaxin colocalization
(4562%; Fig. 1C,D). Additional experiments were designed to
analyze the inner face of PC12 native plasma membrane sheets.
Tat clusters were detected on these membrane lawns only when
cells were incubated with Tat and chased for 4 hours (Fig. 1E),
Fig. 1. Extracellular Tat is internalized
by endocytosis in neurosecretory cells.
PC12 cells were treated with exogenous
recombinant Tat protein (50 nM) for
30 min on ice. Cells were washed and
either immediately fixed (0 min) or chased
at 37 C˚ for the indicated times and then
fixed. Cells were then permeabilized with
saponin and processed for Tat and EEA1
(A) or syntaxin 1A (C) immunolabeling.
Representative median confocal sections
of at least 20 cells per condition are shown.
Mask images highlight the colocalization
staining of Tat and syntaxin 1A or EEA1 at
different time points. Arrowheads indicate
thin plasma membrane Tat staining. Scale
bars: 10 mm. Quantification of the
colocalization level between Tat and
EEA1 (B) or syntaxin 1A (D) was
measured at different time points of chase
(11#n#20 cells for each time point).
Quantification revealed maximal
colocalization of Tat with EEA1 after a
20 min chase [B; Pearson’s correlation
coefficient (PCF): 0.6260.01], and of Tat
with syntaxin after 4 hours of chase
(D; PCF: 0.5760.02). (E) Plasma
membrane sheets prepared from PC12
cells incubated for 30 min with 50 nM Tat
on ice (no chase) or from cells incubated
with Tat and subsequently chased for
4 hours at 37 C˚ (chase). Membrane sheets
were then processed for Tat and syntaxin
1A immunolabeling. Scale bars: 10 mm.
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suggesting that Tat associates with the inner leaflet of the plasma
membrane. In agreement, permeabilization with saponin was
required to detect Tat staining on intact fixed cells after 20 min
or longer chase periods. Together, these data suggest that in
neuroendocrine cells (similar observations were obtained with
bovine chromaffin cells; data not shown), exogenous Tat can be
internalized by endocytosis into early endosomal structures,
reach late endosomes and subsequently escape to bind to the
plasma membrane inner leaflet, with kinetics that are similar to
those described in neurons (Liu et al., 2000).
Tat inhibits chromaffin and PC12 cell exocytosis
Because Tat binds with high affinity to PtdIns(4,5)P2 (Rayne et al.,
2010b), a key lipid for exocytosis, we examined the effect of Tat
on chromaffin cell catecholamine secretion using carbon-fiber
amperometry. Bovine chromaffin cells in primary culture were
incubated in the presence of Tat for 4 hours and then stimulated by
a local application of nicotine. We found that the number of
amperometric spikes reflecting exocytotic fusion events was
strongly decreased in Tat-exposed cells compared to control
cells (Fig. 2A). Tat decreased by more than 50% the number of
spikes per cell evoked by stimulation with either nicotine or a
depolarizing concentration of K+ (Fig. 2B). The kinetic parameters
(rising and decay time, half-width) of the remaining spikes were,
however, unaffected (Fig. 2C), indicating that Tat inhibited
catecholamine secretion by decreasing the frequency of fusion
events. We verified using TRM labeling, that Tat did not trigger
apoptosis under these experimental conditions (data not shown).
The effect of Tat on PC12 cell exocytosis was assessed in cells
expressing human growth hormone (GH) (Vitale et al., 2001).
Because GH is stored in secretory granules and released by
exocytosis, it can be used as a secretory activity reporter.
Extracellular Tat inhibited ATP-evoked GH release from PC12
cells in a time- and dose-dependent manner (Fig. 2D,E). At
10 nM, Tat produced a significant inhibitory effect on GH
secretion whereas the boiled Tat protein was without effect
(Fig. 2E). Similar observations were obtained with PC12 cells
stimulated with a depolarizing K+ concentration (data not
shown). Note that the GH expression level (,400 pg/105 cells)
was not affected by the Tat concentrations used in these studies
(supplementary material Fig. S2).
We then examined the effect of transient Tat expression on ATP-
evoked GH release from PC12 cells. Transfections enabled us to
use various Tat mutants that were unable to penetrate
neurosecretory cells. When transiently expressed, Tat inhibited
ATP-evoked GH release from PC12 cells (see Fig. 5), suggesting
that expressed Tat reproduces the effect of exogenous Tat
incubation on regulated exocytosis. Transfected Tat also strongly
inhibited GH release triggered by 20 mM free calcium in PC12 cells
permeabilized with digitonin to bypass the secretagogue-evoked
Fig. 2. Tat inhibits neurosecretion from bovine primary
chromaffin and PC12 cells. (A) Amperometric recordings of
catecholamine release in response to a local application of
nicotine in control or Tat-treated (50 nM for 4 hours)
chromaffin cells. A typical amperometric profile is shown for
each condition. Control cells received vehicle only (citrate
buffer). (B) Quantification of the number of fusion events/
cell in response to 100 mM nicotine or 100 mM K+
stimulation. The number of spikes was quantified for 60 sec
after stimulation in 14#n#25 cells from three different cell
cultures. Values are means 6 s.e.m., ***P,0.001 compared
to the corresponding control condition. (C) Average
individual spike from control (dotted trace) and Tat-treated
cells (black trace). (D) PC12 cells expressing GH were
incubated in the presence of 50 nM Tat protein (30 min on
ice then chased for 0.5 to 4 hours). GH secretion was then
triggered by 300 mM ATP and released hormone was
quantified after 5 min of stimulation. Control cells received
vehicle only. Data are means 6 s.e.m. from four experiments
performed in quadruplicate on three independent cell cultures
(***P,0.001 compared to the control condition). (E) Dose-
dependent effect of exogenously supplied Tat (filled
diamonds) or boiled Tat (open diamonds) on ATP-evoked
GH secretion from PC12 cells. Data are means 6 s.e.m. of
two experiments performed in triplicate obtained from two
different cell cultures (*P,0.05, **P,0.01 compared to the
control condition). (F) PC12 cells were co-transfected with a
plasmid expressing GH and a bicistronic vector expressing
EGFP (ctrl) or Tat and EGFP (Tat). 24 hours after co-
transfection, cells were permeabilized with digitonin and GH
release estimated in calcium-free medium for resting
condition (basal, open bars) or in response to 20 mM free
calcium for stimulated condition (20 mM Ca2+, grey bars).
Data are means 6 s.e.m. of four experiments performed in
triplicate, obtained from three different cell cultures
(***P,0.001 compared to the stimulated control condition).
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calcium rise (Fig. 2F). Thus, Tat inhibits secretion at a step located
downstream of the rise in cytosolic calcium, probably through a
direct perturbation of the exocytotic machinery. Accordingly,
using Fluo-4 dye to measure cytosolic calcium levels, we found
that the transient calcium rise in response to cell stimulation was
similar in control and Tat-expressing PC12 cells (supplementary
material Fig. S3).
Tat requires binding to PtdIns(4,5)P2 to inhibit secretion
When expressed in PC12 cells using a bicistronic plasmid that
encodes both EGFP and Tat, Tat was found to colocalize with
the plasma membrane marker SNAP-25 (Fig. 3A) and
with PtdIns(4,5)P2 at the cell periphery (Fig. 3B). A similar
localization was observed in chromaffin cells (supplementary
material Fig. S4). Interestingly, Tat was efficiently displaced
from the plasma membrane to the cytosol by neomycin, a
PtdIns(4,5)P2 masking drug (Fig. 3C). A semi-quantitative
analysis revealed that neomycin reduced by nearly 50% the
peripheral Tat (Fig. 3C), indicating that the association of Tat
with the plasma membrane depends on PtdIns(4,5)P2 binding.
To further support the notion that Tat localization at the cell
periphery is dependent on PtdIns(4,5)P2 level, we co-expressed
in PC12 cells Tat and a drug-inducible type IV 5-phosphatase
(Be´gle´ et al., 2009) or the PtdIns(4,5)P2 5-phosphatase
synaptojanin to reduce PtdIns(4,5)P2 levels. In both type of
experiments, reduction of PtdIns(4,5)P2 levels strongly affected
the peripheral distribution of Tat, which became largely cytosolic
(Fig. 4). Altogether, these observations indicate that, in
neuroendocrine cells, Tat either expressed or applied
exogenously and internalized by endocytosis, tends to associate
in a PtdIns(4,5)P2-dependent manner to the plasma membrane.
Next, we investigated whether the inhibitory effect of Tat on
neurosecretion might be linked to its binding to PtdIns(4,5)P2. To
this end, PC12 cells were transfected with plasmids encoding
different Tat mutants and probed for GH secretion. The
expression levels of Tat mutants were similar to that of the
wild-type Tat protein (supplementary material Fig. S5). As
illustrated in Fig. 5, expression of Tat(49–51)A that does not bind
to PtdIns(4,5)P2 (Rayne et al., 2010b) did not affect
secretagogue-evoked GH secretion, whereas expression of
Tat(55–57)A, also mutated in the basic region but still able to
bind to PtdIns(4,5)P2, inhibited GH release like wild-type Tat
(Fig. 5A). Moreover, secretory activity was unaffected by the
expression of the TatW11Y mutant that preserves the native
structure and transactivation activity of Tat (Yezid et al., 2009),
but does not bind PtdIns(4,5)P2 (Rayne et al., 2010b) (Fig. 5A).
Note that Tat(49–51)A accumulated mostly in the cytoplasm,
whereas Tat(55–57)A was found at the cell periphery like the
wild-type Tat protein (supplementary material Fig. S4). Thus, the
interaction of Tat with PtdIns(4,5)P2 at the plasma membrane
seems to be necessary for Tat to block exocytosis.
To confirm these results, we examined whether increasing the
intracellular PtdIns(4,5)P2 concentration by overexpressing the
phosphatidylinositol 4 phosphate 5-kinase Ic (PIP5KIc) isoform
could counteract the inhibitory effect of Tat on secretion.
PIP5KIc is the major PtdIns(4,5)P2 synthesizing enzyme in
neurosecreting cells, and its overexpression has previously been
shown to increase the amount of PtdIns(4,5)P2 at the plasma
membrane by ,5-fold (Be´gle´ et al., 2009; van den Bout and
Divecha, 2009). As illustrated in Fig. 5B, overexpression of
PIP5KIc did not significantly modify GH release from PC12
cells, indicating that PtdIns(4,5)P2 concentration is not a limiting
factor for secretion. However, overexpression of PIP5KIc did
significantly reduce the inhibitory effect of Tat on exocytosis
(Fig. 5B). Note that this rescuing effect on Tat-mediated
inhibition of secretion was not due to a downregulation of Tat
expression (Fig. 5C,D). Altogether, these data strongly suggest
that impairment of secretion by Tat is linked to its binding
capacity to PtdIns(4,5)P2 at the plasma membrane.
Tat interferes with PtdIns(4,5)P2-dependent components of
the exocytotic machinery
Neuronal exocytosis requires the presence of PtdIns(4,5)P2 at the
plasma membrane (Aoyagi et al., 2005; Milosevic et al., 2005;
Fig. 3. Intracellular localization of transfected Tat in PC12 cells.
Cells were transfected with a bicistronic plasmid expressing Tat and
EGFP proteins separately. (A) Distribution of Tat and the plasma
membrane marker SNAP-25 immunostaining. (B) Distribution of Tat and
PtdIns(4,5)P2 [PI(4,5)P2] immunolabeling. Representative, median
confocal sections are shown. (C) Localization of Tat in PC12 cells after
neomycin treatment. Cells were transfected as above and 24 hours after
transfection, cells were treated with 4 or 8 mM neomycin for 1 hour. The
subcellular localization of Tat was assessed by immunofluorescence.
Representative confocal micrographs are shown. Scale bars: 10 mm. The
graph shows the quantification of Tat fluorescence at cell periphery in
confocal sections, expressed as a ratio of fluorescence densities (Df) at
cell periphery compared to cytoplasm. Mean values 6 s.e.m. are shown
(n.9 cells in each condition; *P,0.05; **P,0.01 compared to the
control condition).
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James et al., 2008; Wen et al., 2011). The amount of plasma
membrane located PtdIns(4,5)P2 determines various parameters
of exocytosis, most likely through the interaction with proteins
involved in docking, priming and/or fusion (Umbrecht-Jenck
et al., 2010; Di Paolo and De Camilli, 2006; James et al., 2008;
Rescher et al., 2004; van den Bout and Divecha, 2009). Thus, one
hypothesis might be that Tat interferes with the PtdIns(4,5)P2-
mediated recruitment of constituent(s) of the exocytotic
machinery to the plasma membrane. Annexin A2 is a well
known PtdIns(4,5)P2-binding protein recruited to the plasma
membrane at early stages of exocytosis in chromaffin and PC12
cells (Umbrecht-Jenck et al., 2010). Annexin A2 is cytosolic in
resting cells. Secretagogue-evoked stimulation triggers its rapid
translocation to the plasma membrane (Fig. 6A), where it
stabilizes lipid micro-domains required for exocytosis
(Chasserot-Golaz et al., 2005). In Tat-expressing PC12 cells,
neither ATP (Fig. 6A) nor Ba2+ or high K+ (data not shown) were
able to induce the translocation of annexin A2 to the cell
periphery. Semi-quantitative analysis (Fig. 6C) confirmed that
annexin A2 recruitment to the plasma membrane was severely
impaired in cells expressing Tat whereas expression of the
Tat(49–51)A mutant which is unable to bind PtdIns(4,5)P2 had
no effect (Fig. 6B,C). These experiments suggest that, through its
ability to bind PtdIns(4,5)P2, Tat may also affect the lipid
organizing activity of annexin A2 required for exocytosis.
Because PtdIns(4,5)P2 is also able to bind and modulate
several actin regulatory proteins known to mediate the actin
redistribution required for exocytosis in neuroendocrine cells
(Trifaro´ et al., 2008), we monitored actin depolymerization at the
cell periphery using fluorescent phalloidin. As illustrated in
Fig. 7, PC12 cell stimulation reduced peripheral phalloidin
staining in line with the transient actin reorganization occurring
in cells undergoing exocytosis. Expression of Tat impaired
peripheral actin depolymerization (Fig. 7A,C), whereas Tat(49–
51)A had no effect (Fig. 7B,C). In other words, Tat through its
binding to PtdIns(4,5)P2 interfered with the subplasmalemmal
actin reorganization in stimulated cells, an effect that may also be
involved in its capacity to impair the exocytotic response.
Discussion
Tat protein plays a pivotal role in the control of transcription and
replication of HIV-1 (Coiras et al., 2010). Although Tat function
has been thought for a long time to be restricted to the control of
viral RNA production (Chiu et al., 2002), recent findings
indicated that Tat binds to PtdIns(4,5)P2 with a very high
affinity at the plasma membrane. This binding is required for Tat
release to extracellular space (Rayne et al., 2010b). Strikingly,
the capacity of Tat to be endocytosed and reach the cytosol in
many cell types (Debaisieux et al., 2012) suggests that circulating
Tat might interfere with key cellular processes relying on
PtdIns(4,5)P2 such as endocytosis, phagocytosis, exocytosis, cell
migration and division (Di Paolo and De Camilli, 2006).
We describe here that Tat taken up by an endocytotic pathway
or expressed by transient transfection inhibits secretion from
neuroendocrine chromaffin and PC12 cells, probably through its
binding to PtdIns(4,5)P2 at the plasma membrane. We found that
Tat affected the PtdIns(4,5)P2-mediated recruitment of annexin
A2, a key component of the exocytotic machinery. Tat also
interferes with the peripheral actin cytoskeleton reorganization
upon neuroexocytosis, thereby compromising the secretory
response at a step following the rise in cytosolic calcium.
Tat uptake by neurosecretory cells
HIV-1-infected cells massively export Tat (Ensoli et al., 1990;
Rayne et al., 2010a; Rayne et al., 2010b) and extracellular Tat
can enter into various cell types via multiple endocytic routes
(Liu et al., 2000; Tyagi et al., 2001). We report here that like in
neurons (Liu et al., 2000), Tat is efficiently internalized in
neurosecretory chromaffin and PC12 cells, making these two
models suitable to study the effect of Tat on neurosecretion.
Consistent with the Tat uptake pathway observed in other cell
types (Liu et al., 2000; Vendeville et al., 2004), our results show
that internalized Tat is first found in early endosomal structures
as revealed by colocalization with EEA1, then in Lamp-1-
positive structures. After 4 hours, Tat-containing vesicular
Fig. 4. Tat is partially redistributed to the cytoplasm upon reduction of
the PtdIns(4,5)P2 level. (A) PC12 cells were transfected with type IV 5-
phosphatase fused to FKBP-12–mRFP (5-Ptase-RFP) and FRB–CFP.
24 hours after transfection, cells were incubated for 6 minutes with control
buffer (Ctrl) or 100 nM rapamycin (Rapa) to induce 5-phosphatase
translocation to the plasma membrane. After rapamycin treatment, Tat
displayed a cytoplasmic distribution. Scale bar: 10 mm. (B) PC12 cells co-
expressing synaptojanin-GFP and Tat were stained for Tat and PtdIns(4,5)P2.
Expression of synaptojanin reduced PtdIns(4,5)P2 signal and partially
relocated Tat to the cytoplasm. Scale bar: 10 mm. (C) Quantification of Tat
fluorescent signal at cell periphery in confocal sections expressed as ratio of
fluorescence densities (Df) at cell periphery compared to cytoplasm. Mean
values 6 s.e.m. are shown (n.21 cells in each condition; ***P,0.001
compared to the control condition).
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structures were barely detectable suggesting that endocytosed Tat
progressively dissipates into the cytosol, due to translocation
across the endosome membrane (Vendeville et al., 2004; Yezid
et al., 2009). Concomitantly, Tat signal became evident on the
inner leaflet of the plasma membrane as revealed on plasma
membrane sheets prepared from Tat-exposed cells. When
transfected and expressed in PC12 cells, Tat localized
essentially at the plasma membrane. The binding of Tat to
PtdIns(4,5)P2 is most likely responsible for this recruitment of
Tat to the plasma membrane because both neomycin, a
PtdIns(4,5)P2 masking drug, and PtdIns(4,5)P2 5-phosphatases,
which reduce cellular PtdIns(4,5)P2 levels when overexpressed,
efficiently displaced Tat from the plasma membrane to the
cytosol.
Molecular basis underlying the inhibitory effect of Tat
on neurosecretion
We investigated the effect of Tat on neurosecretion using
chromaffin cells to monitor exocytosis by amperometry (Bader
et al., 2002; Bader and Vitale, 2009). In this cell type, Tat
strongly inhibited the number of exocytotic events induced by
two different secretagogues (nicotine, high K+), as revealed by a
reduction in amperometric spike frequency. Tat also inhibited
hormone release from intact PC12 cells stimulated by various
secretagogues and from permeabilized PC12 cells in which the
intracellular calcium level was buffered at 20 mM. These data
indicate that the impairment of secretion was not the consequence
of an altered calcium signal, but most likely resulted from a direct
effect of Tat on the exocytotic machinery. Accordingly, using a
fluorescent calcium dye, we found that Tat did not modify the
secretagogue-evoked rise in intracellular calcium.
Using Tat mutants unable to bind PtdIns(4,5)P2, we
demonstrated that inhibition of secretion was directly linked to
the interaction of Tat with PtdIns(4,5)P2 at the plasma
membrane. TatW11Y was especially informative since this
mutant shows native transcriptional activity (Yezid et al.,
2009), but no significant binding to PtdIns(4,5)P2 (Rayne et al.,
2010b). The fact that it did not modify secretion indicated that
Tat transcriptional activity was not involved in the inhibition of
secretory activity. Additionally, PIP5K was able to rescue
secretion from cells exposed to Tat, confirming the idea that
Tat blocks secretion through its capacity to bind to the plasma
membrane-associated PtdIns(4,5)P2 with high affinity.
We attempted to identify the PtdIns(4,5)P2-binding
components of the exocytotic machinery that might be
displaced by Tat when present at the plasma membrane.
Translocation of the PtdIns(4,5)P2-binding protein annexin A2
to the plasma membrane following cell stimulation is a hallmark
Fig. 5. Tat inhibitory effect on neurosecretion relies
on PtdIns(4,5)P2 interaction. (A) PC12 cells were
transfected with plasmids encoding GH and Tat or the
indicated Tat mutants. 24 hours after transfection, GH
secretion was evoked with ATP and quantified. Results
are means 6 s.e.m. of three experiments performed in
triplicate on cells derived from three different cell
cultures (***P,0.001 compared to the stimulated control
condition). (B) Rescue of Tat inhibitory effect on GH
release by overexpression of PIP5Kc. Cells were
transfected as indicated using an empty vector (ctrl), a Tat
or a PIP5Kc-expressing plasmid. The total amount of
DNA was kept constant using the empty vector. GH
release is represented as the percentage of total GH
expressed by the cells. Data are means 6 s.e.m. of three
to five experiments performed in triplicate on independent
cell cultures (***P,0.001 compared to the stimulated
control condition; **P,0.005 when compared to the
stimulated control condition in cells coexpressing
PIP5Kc). (C) Western blot analysis showing Tat
expression level in control and PIP5Kc-expressing PC12
cells. PC12 cells were transfected with Tat or PIP5Kc-
expressing vectors as indicated. 40 mg of total cellular
protein extracts were loaded on gels and membranes were
processed for anti-actin and anti-Tat immunolabeling. As
positive control for Tat detection, 30 ng of recombinant
Tat were loaded. (D) Quantification of western blots
shown in C, expressed as integrated density per surface
unit in arbitrary units (A.U.) and normalized to actin
levels. Results are means 6 s.e.m. of three experiments
performed in duplicate on cells derived from three
different cell cultures.
HIV-1 Tat inhibits neurosecretion 459
J
o
u
rn
a
l
o
f
C
e
ll
S
c
ie
n
c
e
of chromaffin cell exocytosis. Annexin A2 plays an essential role
in calcium-regulated exocytosis by promoting ganglioside GM1/
cholesterol-containing lipid regions in the plasma membrane
(Chasserot-Golaz et al., 2005; Chasserot-Golaz et al., 2010;
Umbrecht-Jenck et al., 2010). We recently described that, at
the plasma membrane, annexin A2 is found in the vicinity of
docked secretory granules, colocalizing with syntaxin-1A in
PtdIns(4,5)P2-enriched domains (Umbrecht-Jenck et al., 2010),
and proposed that annexin A2 is a promoter or stabilizer of
genuine exocytotic platforms in neuroendocrine cells. As shown
here, Tat is able to displace annexin A2 from the cell periphery in
stimulated cells, suggesting that the high affinity binding of Tat
to PtdIns(4,5)P2 interferes with the recruitment of annexin A2.
Annexin A2 could in principle bind to other acidic lipids present
at the inner surface of the plasma membrane such as
phosphatidylserine (PS). However, compared to PtdIns(4,5)P2,
Tat does not significantly interact with PS (Rayne et al., 2010b).
The fact that annexin A2 recruitment is severely impaired in Tat-
expressing cells is also an indication that binding to PtdIns(4,5)P2
is most likely the trigger for the recruitment of annexin A2 to the
plasma membrane in cells stimulated for exocytosis. Impairment
of annexin A2 translocation in cells exposed to Tat might led to a
reduction in the number of functional exocytotic sites and, as
observed here, to a concomitant decrease in the number of
exocytotic events.
The cortical F-actin network constitutes a negative clamp on
the movement of secretory vesicles to release sites, and it must be
locally disassembled and reorganized to allow translocation of
secretory vesicles in preparation for exocytosis (Vitale et al.,
1995). During stimulation, the entry of Ca2+ activates scinderin
and gelsolin, which in turn provoke the disassembly of the
cortical F-actin network. The activity and the binding to actin of
Fig. 6. Tat inhibits annexin A2 recruitment to the plasma membrane in
stimulated PC12 cells. PC12 cells were transfected with a vector encoding
Tat and EGFP (A) or Tat(49–51)A and EGFP (B). After 24 hours, cells were
stimulated with 300 mM ATP for 3 min before fixation and immunostaining
for endogenous annexin A2. Representative confocal micrographs are shown.
Scale bars: 10 mm. (C) Quantification of annexin A2 fluorescence at the cell
periphery compared to the cytoplasm. Results are expressed as the ratio of
fluorescence densities (Df) at the cell periphery versus the cytoplasm. Mean
values 6 s.e.m. are shown [n527 for Ctrl and Tat, n514 for Tat(49–51)A;
***P,0.001 compared to the control stimulated condition].
Fig. 7. Tat inhibits cortical actin depolymerization in stimulated PC12
cells. PC12 cells were transfected with a vector encoding Tat and EGFP
(A) or Tat(49–51)A and EGFP (B). After 24 hours, cells were stimulated with
300 mM ATP for 3 min before fixation and phalloidin staining. Scale bars: 10
mm. (C) Quantification of fluorescent phalloidin signal intensities at the cell
periphery. Results are expressed as integrated density per surface unit in
arbitrary units (A.U.). Mean values 6 s.e.m. are plotted [n522 for Ctrl and
Tat, n512 for Tat(49–51)A]. *P,0.05; ***P,0.001 when compared to the
respective resting condition.
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these two F-actin severing proteins that are constituents of the
exocytotic machinery have been shown to be regulated by
PtdIns(4,5)P2 (Trifaro´ et al., 2008). Thus the observation that
Tat hampers the actin cytoskeleton reorganization during
neurosecretion may also be a direct consequence of Tat binding
to PtdIns(4,5)P2.
Altogether, our findings suggest that the inhibitory effect of
Tat on neurosecretion is linked to its high affinity binding to
PtdIns(4,5)P2, which interferes with important components of the
exocytotic machinery relying on PtdIns(4,5)P2. Inhibition of
secretion was observed at nM concentrations of Tat, comparable
with the concentrations reported for circulating Tat (Westendorp
et al., 1995; Xiao et al., 2000), thereby arguing for the
physiological significance of our findings. Yet, the ability of
Tat to inhibit the exocytotic machinery, once present at the inner
face of the plasma membrane, remains an intriguing observation.
Intracellular PtdIns(4,5)P2 concentrations have been estimated in
the micromolar range (McLaughlin et al., 2002). It is therefore
difficult to postulate that Tat may titrate the entire pool of cellular
PtdIns(4,5)P2 and impact its availability, especially when
exogenously supplied. One hypothesis is that Tat efficiently
binds and concentrates at specific location of the plasma
membrane, like the exocytotic sites characterized by a specific
protein and lipid composition. This would confer a preferential
titration of the PtdIns(4,5)P2 at these sites and directly impair the
exocytotic machinery. Alternatively, Tat may efficiently activate
PtdIns(4,5)P2-catalyzing pathways or inhibit the synthesis of
PtdIns(4,5)P2. Either way, these combined effects at exocytotic
sites during stimulation may efficiently starve the exocytotic
machinery from the required PtdIns(4,5)P2.
Pathological relevance
HIV-1 infection frequently leads to neurological disorders such
as depression, motor dysfunction, and cognitive problems (Li
et al., 2009). Because HIV-1 does not infect neurons, indirect
mechanisms are probably responsible for neurological problems
(King et al., 2006) and likely involve viral proteins like Tat
(Ghafouri et al., 2006). Indeed, Tat can be toxic to neurons via
glial cell activation (Ghafouri et al., 2006; King et al., 2006). Tat
can also induce reversible synapse loss in primary neuron
cultures (Kim et al., 2008) and completely capsize neuron/glia
ratio in the hippocampus (Fitting et al., 2010). In addition, it is
becoming increasingly apparent that Tat can directly alter
neuronal functions (Neri et al., 2007). For instance, Tat is able
to activate NMDA receptors by receptor phosphorylation (King
et al., 2010; Li et al., 2008; Neri et al., 2007). Tat also appears to
have an impact on dopamine (Ferris et al., 2009), norepinephrine
(Longordo et al., 2006), glutamate and GABA release (Musante
et al., 2010). Moreover, it was recently shown that Tat
application increased dorsal root ganglion neuron excitability
(Chi et al., 2011). Although these findings suggest that Tat is able
to affect neurotransmission, direct evidence of a Tat effect on the
molecular process of exocytosis has been missing.
We demonstrate here for the first time that Tat directly
affects exocytosis of large dense core secretory granules in
neuroendocrine cells as early as a few hours after application.
Using the classical synaptic vesicle (SV) dye FM1-43, we
observed that Tat prevented vesicle loading in primary neurons
(supplementary material Fig. S6). Since SV loading requires
efficient exocytosis and subsequent endocytosis, these findings
suggest that Tat also affects the exo-endocytosis cycle in neurons.
Therefore, it is likely that Tat perturbs SV trafficking and thus
influences neurotransmitter release, as suggested earlier (Neri
et al., 2007).
HIV-1-infected patients not only develop AIDS, but also
several other serious related pathologies. These include
lypohypertrophy due to decrease in growth hormone secretion
(Leung and Glesby, 2011), pubertal delay caused by the
dysregulation of hypothalamic-pituitary axis (Majaliwa et al.,
2009) and impaired thyroid functions (Hoffmann and Brown,
2007). All of these aberrant functions are linked to impaired
hormone secretion, in line with the results presented here.
In conclusion altered neurotransmission and hormone secretion
may contribute to the development of neurological dysfunctions in
HIV-infected patients. Tat-mediated inhibition of neurosecretion is
likely involved in the development of HIV-1-associated disorders
that arise even in patients treated by highly active antiretroviral
therapy (Ghafouri et al., 2006).
Materials and Methods
Reagents, expression vectors and antibodies
Fluo-4 direct calcium assay kit and FM1-43FX styryl dye were purchased from
Molecular Probes. hGH ELISA kits were from Roche Applied Science,
Lipofectamine 2000 from Invitrogen, and basic Nucleofector Kit from Lonza/
Amaxa Biosystem. Recombinant Tat (BH10 isolate, 86 amino acids) was produced
and purified from E. coli as described (Vendeville et al., 2004). Expression vectors
coding for HIV-1 Tat or Tat mutants (BH10 isolate, 86 residues) were as described
(Rayne et al., 2010a).
Mouse monoclonal anti-HIV-1 Tat antibody (sc-65912) and rabbit polyclonal
anti-syntaxin 1A were from Santa Cruz Biotechnology. Mouse monoclonal and
rabbit polyclonal anti-SNAP-25, and rabbit polyclonal anti-human GH were
obtained as indicated (Be´gle´ et al., 2009). Monoclonal anti-PtdIns(4,5)P2 antibody
(IgM) was purchased from Abcam (2C11). Rabbit polyclonal antibody against
early endosomal antigen (EEA1) was from Abcam. Alexa-Fluor-488, -555 or
-647-labeled secondary anti-mouse and anti-rabbit antibodies were obtained from
Molecular Probes. The GFP-synaptojanin and inducible 5-phosphatase plasmids
were kindly provided by Drs P. De Camilli (Yale School of Medicine) and T. Balla
(NICHD, NIH), respectively.
Cell cultures
PC12 cells were cultured as described previously (Zeniou-Meyer et al., 2007).
Freshly dissected primary bovine chromaffin cells were cultured in DMEM in the
presence of 10% foetal calf serum, 10 mM cytosine arabinoside, 10 mM
fluorodeoxyuridine and antibiotics as described previously (Vitale et al., 1993).
Cell incubation with recombinant Tat
Treatment of PC12 or chromaffin cells with exogenous recombinant HIV-1 Tat
protein or citrate buffer (vehicle, 50 mM sodium citrate, 100 mM NaCl, pH 7) was
performed the day after cell seeding, or 72 hours after plating, respectively. Cells
were incubated with 50 nM Tat for 30 min on ice to allow Tat binding to cells.
Cells were then washed three times with Locke’s buffer (140 mM NaCl, 4.7 mM
KCl, 2.5 mM CaCl2, 1.2 mM MgSO4, 15 mM HEPES and 11 mM glucose,
pH 7.4) and either immediately fixed (time 0 min or no chase) or put into the
incubator at 37 C˚ (chase) for various periods of time before fixation or cell
stimulation. Using the in situ cell death detection kit, TMR red (Roche), we found
that Tat treatment and overexpression did not induce apoptosis in PC12 cells.
Transfection
pBi-Tat, phGH, and pPIP5KIc expression vectors (0.8 to 1 mg total DNA, 156104
cells, 24-well plate) were introduced into PC12 cells using Lipofectamine 2000.
Chromaffin cells were transfected by Amaxa Nucleofector (Lonza/Amaxa
Biosystem) according to the manufacturer’s protocol (3 mg DNA, 56106 cells,
24-well plate). Under these conditions, transfection efficiency ranged from 60 to
75% for PC12 cells and from 20 to 40% for chromaffin cells. Co-transfection
efficacy was systematically verified by immunostaining and was between 80 and
90%. Experiments were performed 24 hours after transfection.
Plasma membrane sheet preparation
Plasma membrane sheets were prepared according to the following protocol. After
incubation with exogenous recombinant Tat for 30 min on ice, cells on coverslips
were washed four times with Locke’s solution and, when indicated, incubated for
4 hours at 37 C˚ to allow Tat internalization. Cells were then submitted to
hypotonic shock with water to burst cells following the lysis-squirting procedure
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described previously (Ziegler et al., 1998). Plasma membrane sheets attached on
the coverslip were fixed with 2% paraformaldehyde at 4 C˚ during 2 hours and
labeled with anti-Tat or anti-syntaxin 1A antibodies.
Immunofluorescence and confocal microscopy
PC12 or chromaffin cells were washed twice with warm Locke’s solution and
stimulated 5 min with Locke’s solution containing a depolarizing concentration of
potassium (59 mM) or 300 mM ATP before fixation by 4% paraformaldehyde in
120 mM phosphate buffer and permeabilization with 0.025% saponin in
phosphate-buffered saline containing 0.1% BSA at room temperature. Cells were
further processed for anti-Tat (1:200), anti-EEA1 (1:500), anti-GH (1:200), anti-
SNAP-25 (1:200), anti-syntaxin 1A (1:150) or anti-annexin A2 (1:200)
immunofluorescence as described previously (Be´gle´ et al., 2009). Fixation and
anti-PtdIns(4,5)P2 (1:100) staining were performed on ice as described (Hammond
et al., 2006; Hammond et al., 2009). Stained cells were visualized using a SP5II
Leica or LSM 510 Zeiss confocal microscope equipped with a 636 objective.
Median confocal sections were recorded and quantified as indicated below. Images
of membrane sheets were obtained using SP5II Leica with 636objective (NA1.4)
and pinhole adjustment of 0.68 Airy units.
Amperometry
Electrochemical measurements of catecholamine secretion were performed 4–
6 hours after treatment with recombinant Tat protein or vehicle (citrate buffer) as
described previously (Chasserot-Golaz et al., 2005). Catecholamine secretion was
evoked by applying K+ (100 mM) or nicotine (100 mM) in Locke’s solution
without ascorbic acid for 5 seconds to single cells by mean of a glass micropipette
positioned at a distance of 40–50 mm from the cell.
Growth hormone release assay
PC12 cells (156104 cells, 24-well plates, 80% confluence) were transfected with
pBi-Tat (0.6 mg/well) and a plasmid encoding GH (0.3 mg/well) using
Lipofectamine 2000. 24 hours after transfection, cells were washed four times
for 5 min with Locke’s solution and then incubated for 5 min in Locke’s solution
(basal release) or stimulated for 5 min with a depolarizing concentration of K+ or
with 300 mM ATP. Supernatants were collected and cells were harvested by
scrapping in 10 mM phosphate-buffered saline and lyzed by three freeze and thaw
cycles. The amounts of GH secreted into the medium or retained within the cells
were measured using an ELISA assay (Roche Applied Science). GH secretion is
expressed as a percentage of total GH present in the cells before stimulation (Lam
et al., 2008). GH release from permeabilized cells was processed as described
previously (de Barry et al., 2006).
Western blotting
Confluent PC12 cells grown in 3.5 cm diameter dishes were transfected with pBi-
Tat and either an empty vector or a PIP5K-expressing plasmid (4 mg total DNA).
The day after transfection, cells were harvested on ice by scraping in lysis buffer
(10 mM Tris pH 7.4, 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM NaF,
20 mM Na4P2O7, 2 mM Na3VO4, 1% Triton X-100, 10% glycerol, 0.1% SDS,
0.5% deoxycholate and protease inhibitors). Total cellular protein (30–40 mg)
extracts were analyzed on 4–20% polyacrylamide–SDS gels. Immunoblots were
then revealed with anti-actin and anti-Tat antibodies. Blots were processed using
the Super Signal detection system (Pierce) as described previously (Corrotte et al.,
2006). Immunoreactive bands were quantified using ImageJ. Tat band density was
normalized to that of actin from the same lane and expressed as means 6 s.e.m. of
three experiments that were performed in duplicates using three different cell
cultures.
Data and image analysis
Mask images were created with the LasAF Software 2.3.5 (Leica) using the
colocalization application provided. After background threshold determination to
eliminate low intensity pixels, colocalized pixels were visualized on black and
white overlay images (Masks). Immunofluorescence images showing Tat (Figs 3,
4), annexin A2 (Fig. 6) or phalloidin (Fig. 7) staining were quantified using
ImageJ. The amount of Tat or annexin A2 was measured as the average
fluorescence intensity normalized to the corresponding surface area (Df) at the cell
periphery (plasma membrane level) and in the cytoplasm. Results are expressed as
ratios of Df (cell periphery)/Df (cytoplasm). The amount of phalloidin staining was
quantified at the level of cell periphery and expressed as fluorescence intensities
normalized to surface units. This allows a quantitative cell-to-cell comparison of
the fluorescent signal. Colocalization analyses were performed with LasAF
Software 2.3.5 (Leica) using the colocalization application provided. Precisely, the
threshold of each channel was set individually and independently from the other
channel. Cut-off settings of the background fluorescence were generally around
20%, except for the EEA1 antibody, where they were around 30%. The overlay
image and the scatter plot is automatically generated by the software algorithm
resulting in a table that included colocalization percentages and Pearson’s
correlation coefficient (PCF) values.
Statistical significance was estimated using Student’s t-test and data were
considered significantly different when P,0.05. Gaussian distribution of the data
was verified.
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